EURORDIS website
Course 2 – Setting the landscape quiz
Quiz Summary
0 of 8 Questions completed
Questions:
Information
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
Results
Results
0 of 8 Questions answered correctly
Your time:
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
Categories
- Not categorized 0%
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- Current
- Review / Skip
- Answered
- Correct
- Incorrect
-
Question 1 of 8
1. Question
Which of the following is not one of the core objectives of genetics in clinical diagnosis?
CorrectIncorrect -
Question 2 of 8
2. Question
The main benefits of improvements on sequencing methods are… (You will need to select more than one response)
CorrectIncorrect -
Question 3 of 8
3. Question
Which source of funding for rare diseases is a partnership between the European Union
and the European Pharmaceutical Industry?CorrectIncorrect -
Question 4 of 8
4. Question
In which way can patient organizations collaborate with European rare diseases research?
CorrectIncorrect -
Question 5 of 8
5. Question
What are some of the problems that researchers can potentially encounter in translational
research ?I-Limited information about the disease II-Selection of a cohort III-Limited information about testing the efficacy CorrectIncorrect -
Question 6 of 8
6. Question
How did the patient dialogue shape research for therapy development for Duchenne disease?
CorrectIncorrect -
Question 7 of 8
7. Question
How can ERNs impact positively on rare diseases? (You will need to select more than one response)
CorrectIncorrect -
Question 8 of 8
8. Question
An ERN can be formed by clinical centers from one member state.
CorrectIncorrect